Myricetin is effective and selective in inhibiting imatinib-resistant chronic myeloid leukemia stem and differentiated cells through targeting eIF4E : Anti-Cancer Drugs

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Original article

Myricetin is effective and selective in inhibiting imatinib-resistant chronic myeloid leukemia stem and differentiated cells through targeting eIF4E

Cai, Fangfang*,; Li, Bibao*,; Li, Jiang*,; Ding, Yong; Xu, Dandan; Huang, Fei

Author Information
Anti-Cancer Drugs: November 18, 2022 - Volume - Issue - 10.1097/CAD.0000000000001421
doi: 10.1097/CAD.0000000000001421
  • Buy
  • PAP

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.